An experience of using Rivaroxaban (Xarelto®) in the treatment of lower extremity fractures

Authors

  • Vladislav Palamarchuk
  • Konstantin Bulavin

DOI:

https://doi.org/10.15674/0030-59872010273-74

Keywords:

Rivaroxaban, femur fractures, shin fractures, venous thrombembolism

Abstract

The article contains an analysis of the results of prevention of venous thrombembolism (up to 35 days) in patients with fractures of their femoral and tibial bones, who were subjected to osteosynthesis. Two groups of patients were compared: the 1st was recommended to take Clexane, the 2nd one took Rivaroxaban (Xarelto(R)). In outpatient conditions, the prevention of venous thrombembolism lasted in 12.5 % of patients from the 1st group, and in 70.8 % from the 2nd one.

References

  1. Баешко А.А. Послеоперационный тромбоз глубоких вен нижних конечностей и тромбоэмболия легочной артерии. Эпидемиология. Этиопатогенез. Профилактика [Текст] / А.А. Баешко. — М.: Триада-Х, 2000. — 136 с.
  2. Бокарев И.Н. Венозный тромбоэмболизм: лечение и профилактика [Электронный ресурс] / И.Н. Бокарев, Л.В. Попова, Т.Б. Кондратьев. — Режим доступа: http: // www.consilium-medicum.com /media /surgery /05_01/ 5. shtml.
  3. Вырва О. Е. Сравнительная оценка эффективности ривароксабана и эноксапарина в профилактике тромбообразования после эндопротезирования тазобедренного сустава. Результаты исследований RECORD1 [Текст] / О.Е. Вырва // Ортопед. травматол. — 2009. — № 3. — С. 97–100.
  4. Малиновский Н.Н. Возможна ли надежная профилакти¬ка послеоперационных венозных тромбоэмболических осложнений? [Текст] / Н.Н. Малиновский // Хирургия. — 2001. — № 1. — С. 6–11.
  5. The prevalence ofrisk factors for venous thromboembolism amonghospitalpatients [Text] / F.A. Anderson, H.B. Wheeler, R.J. Goldbergetal. // Arch. Intern. Med. — 1992. — Vol. 152. — P. 1660–1664.
  6. Fondaparinux compared with enoxaparinfor the preventionofvenous thromboembolism after hip fracture surgery [Text] / B.I. Eriksson, K.A. Bauer, M.R. Lassenetal. // N. Engl. J. Med. — 2001. — Vol. 345. — P. 1298–1304.
  7. Eriksson B.I. Oralanticoagulants indevelopment: focus onthromboprophylaxis inpatientundergoingorthopedic surgery [Text] / B.I. Eriksson, D.J. Quinlan// Drugs. — 2006. — Vol. 66. — P. 1411–1429.
  8. Rivaroxabanfor thromboprophylaxis after orthopedic surgery: pooled analysis oftwostudies [Text] / W.D. Fisher, B.I. Eriksson, K.A. Bauer etal. // Thromb. Haemost. — 2007. — Vol. 97. — P. 931–937.
  9. Pulmonary embolism: epidemiology [Text] / C. Giuntini, G. Di Ricco, Marini et al. // Chest. — 1995. — Vol. 107. — P. 3–9.
  10. Turpie A.G. Venous thromboembolism: pathophysiology, clinicalfeatures, and prevention[Text] / A.G. Turpie, B.S. Chin, G.Y. Lip. — Br Med. J. — 2002. — Vol. 325. — P. 887–890.

Downloads

How to Cite

Palamarchuk, V., & Bulavin, K. (2010). An experience of using Rivaroxaban (Xarelto®) in the treatment of lower extremity fractures. ORTHOPAEDICS TRAUMATOLOGY and PROSTHETICS, (2), 73–74. https://doi.org/10.15674/0030-59872010273-74

Issue

No. 2 (2010)

Section

ORIGINAL ARTICLES

License

Copyright (c) 2014 Vladislav Palamarchuk, Konstantin Bulavin

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The authors retain the right of authorship of their manuscript and pass the journal the right of the first publication of this article, which automatically become available from the date of publication under the terms of Creative Commons Attribution License, which allows others to freely distribute the published manuscript with mandatory linking to authors of the original research and the first publication of this one in this journal.

Authors have the right to enter into a separate supplemental agreement on the additional non-exclusive distribution of manuscript in the form in which it was published by the journal (i.e. to put work in electronic storage of an institution or publish as a part of the book) while maintaining the reference to the first publication of the manuscript in this journal.

The editorial policy of the journal allows authors and encourages manuscript accommodation online (i.e. in storage of an institution or on the personal websites) as before submission of the manuscript to the editorial office, and during its editorial processing because it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the published manuscript citation (see The Effect of Open Access).